Cryopreserved Skin - Cryoskin

Location

Description

The supply of allograft Cryoskin for use in the treatment of burn injuries within the Burns Centre. The allograft Cryoskin will be required to support clinical care by providing temporary wound coverage to promote healing, reduce pain, and minimise infection risk in patients with burns. The contract will cover the provision, storage, and delivery of clinically approved allograft Cryoskin products in line with relevant regulatory, safety, and quality standards. Suppliers must demonstrate proven experience in the supply of human tissue allografts and the ability to meet the specialised needs of a tertiary Burns Centre, including reliability of supply and adherence to clinical governance requirements.

Award Detail

CPV Codes

• None found

Legal Justification

Proximity to the Burns Centre Close geographic proximity to the Burns Centre enables rapid access to allograft Cryoskin at short notice. This is particularly critical in burn care, where clinical demand can be urgent and unpredictable. Local availability reduces transportation times and associated risks, ensuring that clinically viable allograft material can be provided promptly to meet patient needs. Rapid Emergency Delivery Capability Innovations has demonstrated the ability to respond quickly to emergency requests, including out‑of‑hours and same‑day deliveries. This capability is essential for the management of acute and severe burn cases, where delays in treatment could significantly impact patient outcomes. Their proven responsiveness supports both emergency interventions and continuity of care. Fully Compliant Storage Arrangements The supplier maintains storage facilities that are fully compliant with all relevant regulatory, quality, and governance requirements for human tissue products. This ensures the integrity, safety, and traceability of Cryoskin throughout the supply chain, providing assurance that products meet the highest clinical and regulatory standards upon delivery and use. Service Continuity and Patient Care Necessary to avoid any disruption to the supply of allograft Cryoskin. Continuity of supply is critical to maintaining service resilience within the Burns Centre and ensuring uninterrupted access to essential allograft material for both emergency and planned procedures. This approach directly supports safe, effective, and timely patient care.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **